| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jan―16 |
Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study |
Andrew Ustianowski, Myron J. Levin, Stephane De Wit, Odile Launay, Bernard Veekmans, Tommy Rampling, James G. Sullivan, Mark Vishnepolsky, Priyantha Wijewardane, Yousef Fawadleh, Huixia Zhang, Meng Li, Dilki Wickramarachchi, Audrey Sharbaugh, Rohini Beavon, Jesse Thissen, Lauren Hirao, Vitalina Dzutseva, Seth Seegobin, Katie Streicher, Alexandre Kiazand, Mark T. Esser, Lee-Jah Chang, John L. Perez, Taylor S. Cohen |
| 2 |
[GO] |
2025―Nov―25 |
Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled Trials |
George N. Okoli, Nicole Askin, Rasheda Rabbani |
| 3 |
[GO] |
2025―Aug―12 |
Spontaneous Reports of Adverse Reactions with Fatal Outcomes After COVID-19 Vaccination During the National Vaccination Campaign in Sweden |
Marja-Leena Nurminen, Per Lindemo, Anders Sundström, Björn Zethelius, Maria Larsson, Sofia Attelind, Nicklas Pihlström, Rickard Ljung, Veronica Arthurson |
| 4 |
[GO] |
2025―May―28 |
Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic |
Sara Karami, Christian Angelo I. Ventura, Ellen Pinnow, Jody Green, Ajoa Asonye, Ibrahim T. Ibrahim, Lynda McCulley, Gerald J Dal Pan, Esther H. Zhou |
| 5 |
[GO] |
2024―Feb―20 |
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C) |
Christopher F. Bell, Priyanka Bobbili, Raj Desai, Daniel C. Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J. Birch, Emily J. Lloyd, Adina Zhang, Mei Sheng Duh |
| 6 |
[GO] |
2023―Sep―22 |
Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency |
Nicola Ughi, Davide Paolo Bernasconi, Francesca Del Gaudio, Armanda Dicuonzo, Alessandro Maloberti, Cristina Giannattasio, Paolo Tarsia, Giovanna Travi, Francesco Scaglione, Fabrizio Colombo, Michaela Bertuzzi, Antonella Adinolfi, Maria Grazia Valsecchi, Claudio Rossetti, Oscar Massimiliano Epis |
| 7 |
[GO] |
2023―Jul―27 |
Evaluating the Association of Montelukast Use on Neuropsychiatry-Related Healthcare Utilization and Depression in COVID-19-Hospitalized Veterans: A Nationwide VA Observational Cohort Study |
Tanvi Patil, Jasper Jade Raguindin, Michelle Radtke, Joseph Smigiel, Natalie Savona, Bush Kavuru, Anuradha Sekhri |
| 8 |
[GO] |
2022―Dec―03 |
Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment |
Xinyu Liu, Jian Shi, Deyang Wang, Ying Su, Zhen Xing, Fei Sun, Fei Chen |
| 9 |
[GO] |
2022―Oct―31 |
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Mohamed Abuelazm, Ahmed Ghanem, Ahmed K. Awad, Ramadan Abdelmoez Farahat, Fatma Labieb, Basant E. Katamesh, Basel Abdelazeem |
| 10 |
[GO] |
2022―Oct―23 |
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study |
Francesco Ferrara, Carolina Mancaniello, Alessia Varriale, Sarah Sorrentino, Andrea Zovi, Eduardo Nava, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello |
| 11 |
[GO] |
2022―Sep―29 |
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities |
José Hernández-Rodríguez, Julio Durán-Sanclemente, Sergio Prieto-González, Olga Araújo, Teresa Hospital-Vidal, Georgina Casanovas, Víctor Sapena, José Luis Blanco, Alfonso López-Soto, Francisco J. Afonso, Jesús Aibar, Xavier Alemany, Luis Aparicio, Yolanda Asensio, Anna Aldea-Parés, Ana B. Azuaga, Giuseppe Barilaro, Nieves Benages, Katherine Cajiao, Júlia Calvo, Maria del Carme Cañueto, Aina Capdevila-Reniu, Irene Carbonell, Miriam Costafreda, Cecilia Cuzco, Anna de-Daniel-Bisbe, Gema Doménech, Mónica Doménech, Gerard Espinosa, Maria Feliu, Alberto Foncillas, Cristina Gabara, Gloria Gámez, Carlos García-Gutiérrez, Lucía García-Jarque, Andrea García-Ortega, Begoña Gómez, Verónica Gómez-Caverzaschi, Vanesa Gómez-Urbano, Tania Gonzalo, Ignacio Grafia, Neus Guasch, Mar Guillén, Ana M. Guió, Marta Illa, Marco Inzitari, Maria Joyera, Andrea Ladino, Irina S. Luzko-Scheid, Gema M. Lledó, Néstor López-Guerra, Daniel Marco, Guillem Masdeu, Ana Matas-García, Irene Macaya, Ferran Masanés, Miriam I. Mayor, José C. Milisenda, Montse Montero, Verónica Montes, Marc Montoya-Rodés, Núria Moragas, Alma Morancho, Pedro J. Moreno, José Naval, Josep Ortega, Anna Pahisa, Martina Pellicé, Sona Pilarcikova, Ester Pujol, Elisabet Rivero, Joan Ribot, Roberto Ríos-Garcés, Olga Rodríguez-Núñez, Omar M. Saavedra, Emilio Sacanella, Adelaido Salazar, Adriana San Miguel, Amparo Sánchez-Buitrago, Víctor Sánchez-Palacios, Ángeles Sanz, Ferran Seguí, Adrià Tomé-Pérez, Manuel Torres-Elorza, Montse Tuset, Helena Ventosa, Roser Ventura, Esther Viñas-Esmel, Carles Zamora |
| 12 |
[GO] |
2022―Sep―14 |
Reporting of COVID-19 Reinfection and Potential Role of Immunosuppressant/Immunomodulating Agents: A Cross-Sectional Observational Analysis Based on a Spontaneous Reporting Database |
Elena Beyzarov, Yan Chen, Patrick Caubel |
| 13 |
[GO] |
2022―Aug―30 |
Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection |
Amjad Alfaleh, Abdullah Alkattan, Abrar Alzaher, Nashwa Radwan, Nagla Mahmoud, Alaa Alageel, Dina Alhabib, Eman Alsalameen, Khlood Sagor, Alhan Haji, Amal Alfaifi, Khaled Alabdulkareem, Mona Ibrahim |
| 14 |
[GO] |
2022―Aug―23 |
Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan |
Derar H. Abdel-Qader, Hasan Abdel-Qader, Jennifer Silverthorne, Chuenjid Kongkaew, Ahmad Z. Al Meslamani, Wail Hayajneh, Osama M. Abu Ata, Walid Shnaigat, Salah AbuRuz, Mohannad Al Nsour, Abdallah Alhariri, Khaldoun Shnewer, Mohammad Da’ssan, Nathir M. Obeidat, Khaldoon E. Nusair, Mothafer S. Jalamdeh, Feras Hawari, Khaldoun Khader, Tareq Hakim, Fatima A. Hammad, Mustafa Al Qudah, Mohammad Asad |
| 15 |
[GO] |
2022―Aug―17 |
Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study |
Ariyon Schreiber, Justin S. Bauzon, Kavita Batra, Salman Mohammed, Kevin Lee, Nazanin Houshmand, Uyen Pham, Celica Cosme, Kim Inciong, Omar Al-Taweel, Keaton Nasser, Jibran Rana, Chris Sossou, Ariel Go, Dalia Hawwass, Jimmy Diep, Chowdhury H. Ahsan |
| 16 |
[GO] |
2022―Jul―15 |
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study |
Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Basem Alraddadi, Alaa Alali, James Jarrett, Sam Kozma, Camille Harfouche, Tariq Al Musawi |
| 17 |
[GO] |
2022―Jul―11 |
Paxlovid-Tacrolimus Drug-Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19 |
Noa Berar Yanay, Ido Bogner, Khader Saker, Elias Tannous |
| 18 |
[GO] |
2022―Jun―09 |
Guillain-Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data |
Marina Atzenhoffer, Marine Auffret, Antoine Pegat, Kamel Masmoudi, Charles Khouri, Blandine Bertin, Thierry Vial |
| 19 |
[GO] |
2022―Mar―17 |
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study |
Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, João Rua, Nuno Luís, Sandra Braz, Filipa Aragão |
| 20 |
[GO] |
2022―Feb―26 |
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis |
Andrea Marcellusi, Gianluca Fabiano, Paolo Sciattella, Massimo Andreoni, Francesco Saverio Mennini |
| 21 |
[GO] |
2021―Oct―23 |
Efficacy of Interferon-β in Moderate-to-Severe Hospitalised Cases of COVID-19: A Systematic Review and Meta-analysis |
Subodh Kumar, Manoj Kumar Saurabh, Venkata Lakshmi Narasimha, Vikas Maharshi |
| 22 |
[GO] |
2021―Oct―09 |
The Cost-Effectiveness of a COVID-19 Vaccine in a Danish Context |
Kristian Debrabant, Lone Grønbæk, Christian Kronborg |
| 23 |
[GO] |
2021―Jul―30 |
Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study |
Heba Wagih Abdelwahab, Shaker Wagih Shaltout, Hazem A. Sayed Ahmed, Ahmed Mahmoud Fouad, Eric Merrell, Jeffrey B. Riley, Rasha Salama, Ahmed Gharib Abdelrahman, Edward Darling, Ghada Fadel, Mohamed S. A. Elfar, Khaled Sabry, Jaffer Shah, Hossam Amin, Gary F. Nieman, Adel Mishriky, Hani Aiash |
| 24 |
[GO] |
2021―Jun―05 |
Correction to: Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges |
Deva Priya Sagili Anthony, Kavitha Sivakumar, Priyanka Venugopal, Damal Kandadai Sriram, Melvin George |
| 25 |
[GO] |
2021―Mar―23 |
Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges |
Sagili Anthony Deva Priya, Shivakumar Kavitha, Priyanka Venugopal, Damal Kandadai Sriram, Melvin George |
| 26 |
[GO] |
2021―Feb―19 |
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19 |
Jan Homolak, Ivan Kodvanj, Vladimir Trkulja |
| 27 |
[GO] |
2021―Feb―10 |
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19 |
Nicolas Hoertel, Marina Sánchez-Rico, Raphaël Vernet, Anne-Sophie Jannot, Antoine Neuraz, Carlos Blanco, Cédric Lemogne, Guillaume Airagnes, Nicolas Paris, Christel Daniel, Alexandre Gramfort, Guillaume Lemaitre, Mélodie Bernaux, Ali Bellamine, Nathanaël Beeker, Frédéric Limosin |
| 28 |
[GO] |
2020―Sep―20 |
Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report |
Caroline Streicher, Xavier Engalenc, Marion Gaudin, Guillaume Vignaud, Annick Daulange, Bruno Abraham |
| 29 |
[GO] |
2020―Aug―20 |
Use of Azithromycin in COVID-19: A Cautionary Tale |
Chia Siang Kow, Syed Shahzad Hasan |
| 30 |
[GO] |
2020―Aug―10 |
Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19? |
Bruno Charpiat, Nathalie Bleyzac, Michel Tod |
| 31 |
[GO] |
2020―Jul―13 |
Tocilizumab, Adipokines and Severe Complications of COVID-19 |
Antonella Fioravanti, Brunetta Porcelli, Lucia Terzuoli, Maria Romana Bacarelli, Sara Tenti, Sara Cheleschi |
| 32 |
[GO] |
2020―Jul―13 |
Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19 |
Bin Liu, Zhigang Qi |
| 33 |
[GO] |
2020―Jun―12 |
Azithromycin for COVID-19: More Than Just an Antimicrobial? |
Nathalie Bleyzac, Sylvain Goutelle, Laurent Bourguignon, Michel Tod |
| 34 |
[GO] |
2020―May―28 |
An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19) |
Saibal Das, Subhrojyoti Bhowmick, Sayali Tiwari, Sukanta Sen |
| 35 |
[GO] |
2020―Apr―26 |
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia |
Shengyu Zhang, Lei Li, Aizong Shen, Yongwu Chen, Zhigang Qi |
|
